Status:

WITHDRAWN

Use Of Virtual Reality For Pain Control in Dermatological Bedside Procedures

Lead Sponsor:

University of Miami

Conditions:

Pain

Eligibility:

All Genders

13+ years

Phase:

NA

Brief Summary

The purpose of this research study is to explore the impact of virtual reality (VR) on pain perception during out-patient procedures such as wart removal, wound debridement, and lidocaine injections.

Eligibility Criteria

Inclusion

  • Patients 13 years and older.
  • Patient (or health care proxy when applicable) must sign an ICF.
  • Patient requiring any painful dermatological bedside procedure including: wound debridement, injections and liquid nitrogen application.
  • Patients willing to participate and parents able to consent.

Exclusion

  • Subjects with a diagnosis of vertigo, inner ear diseases or seizures are excluded due to the uncertainty of performance under VR conditions.
  • Subjects requiring procedures on the head are also excluded to the interference of the VR headset.

Key Trial Info

Start Date :

January 1 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

April 1 2022

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT04287491

Start Date

January 1 2021

End Date

April 1 2022

Last Update

June 16 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Miami

Miami, Florida, United States, 33136